Clinical trial NCT04569565 - References

Ascites Hepatic — Prospective Evaluation of PleurX Drain for Treatment of Cirrhotic Refractory Ascites

Citation(s)

•   Angermayr B, Cejna M, Karnel F, Gschwantler M, Koenig F, Pidlich J, Mendel H, Pichler L, Wichlas M, Kreil A, Schmid M, Ferlitsch A, Lipinski E, Brunner H, Lammer J, Ferenci P, Gangl A, Peck-Radosavljevic M
  Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut. 2003 Jun;52(6):879-85.
•   Arroyo V
  A new method for therapeutic paracentesis: the automated low flow pump system. Comments in the context of the history of paracentesis. J Hepatol. 2013 May;58(5):850-2. doi: 10.1016/j.jhep.2013.01.037. Epub 2013 Feb 8.
•   Bellot P, Welker MW, Soriano G, von Schaewen M, Appenrodt B, Wiest R, Whittaker S, Tzonev R, Handshiev S, Verslype C, Moench C, Zeuzem S, Sauerbruch T, Guarner C, Schott E, Johnson N, Petrov A, Katzarov K, Nevens F, Zapater P, Such J
  Automated low flow pump system for the treatment of refractory ascites: a multi-center safety and efficacy study. J Hepatol. 2013 May;58(5):922-7. doi: 10.1016/j.jhep.2012.12.020. Epub 2013 Jan 11.
•   Campbell MS, Brensinger CM, Sanyal AJ, Gennings C, Wong F, Kowdley KV, McCashland T, Reddy KR
  Quality of life in refractory ascites: transjugular intrahepatic portal-systemic shunting versus medical therapy. Hepatology. 2005 Sep;42(3):635-40.
•   Campillo B, Richardet JP, Scherman E, Bories PN
  Evaluation of nutritional practice in hospitalized cirrhotic patients: results of a prospective study. Nutrition. 2003 Jun;19(6):515-21.
•   Cazzaniga M, Salerno F, Pagnozzi G, Dionigi E, Visentin S, Cirello I, Meregaglia D, Nicolini A
  Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt. Gut. 2007 Jun;56(6):869-75. Epub 2006 Nov 29.
•   Courtney A, Nemcek AA Jr, Rosenberg S, Tutton S, Darcy M, Gordon G
  Prospective evaluation of the PleurX catheter when used to treat recurrent ascites associated with malignancy. J Vasc Interv Radiol. 2008 Dec;19(12):1723-31. doi: 10.1016/j.jvir.2008.09.002. Epub 2008 Oct 31.
•   European Association for the Study of the Liver
  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010 Sep;53(3):397-417. doi: 10.1016/j.jhep.2010.05.004. Epub 2010 Jun 1. Review.
•   Garcia-Tsao G, Parikh CR, Viola A
  Acute kidney injury in cirrhosis. Hepatology. 2008 Dec;48(6):2064-77. doi: 10.1002/hep.22605. Review.
•   Ginès A, Fernández-Esparrach G, Monescillo A, Vila C, Domènech E, Abecasis R, Angeli P, Ruiz-Del-Arbol L, Planas R, Solà R, Ginès P, Terg R, Inglada L, Vaqué P, Salerno F, Vargas V, Clemente G, Quer JC, Jiménez W, Arroyo V, Rodés J
  Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology. 1996 Oct;111(4):1002-10.
•   Johnson TM, Overgard EB, Cohen AE, DiBaise JK
  Nutrition assessment and management in advanced liver disease. Nutr Clin Pract. 2013 Feb;28(1):15-29. doi: 10.1177/0884533612469027. Review.
•   Les I, Doval E, Flavià M, Jacas C, Cárdenas G, Esteban R, Guardia J, Córdoba J
  Quality of life in cirrhosis is related to potentially treatable factors. Eur J Gastroenterol Hepatol. 2010 Feb;22(2):221-7. doi: 10.1097/MEG.0b013e3283319975.
•   Leveen HH, Christoudias G, Ip M, Luft R, Falk G, Grosberg S
  Peritoneo-venous shunting for ascites. Ann Surg. 1974 Oct;180(4):580-91.
•   Llach J, Rimola A, Navasa M, Ginès P, Salmerón JM, Ginès A, Arroyo V, Rodés J
  Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology. 1992 Sep;16(3):724-7.
•   Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A; Acute Kidney Injury Network
  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.
•   Nadir A, Van Thiel DH
  Frequency of peritoneal infections among patients undergoing continuous paracentesis with an indwelling catheter. J Ayub Med Coll Abbottabad. 2010 Jan-Mar;22(1):37-41.
•   Patel PA, Ernst FR, Gunnarsson CL
  Evaluation of hospital complications and costs associated with using ultrasound guidance during abdominal paracentesis procedures. J Med Econ. 2012;15(1):1-7. doi: 10.3111/13696998.2011.628723. Epub 2011 Oct 19.
•   Po CL, Bloom E, Mischler L, Raja RM
  Home ascites drainage using a permanent Tenckhoff catheter. Adv Perit Dial. 1996;12:235-6.
•   Reinglas J, Amjadi K, Petrcich B, Momoli F, Shaw-Stiffel T
  The Palliative Management of Refractory Cirrhotic Ascites Using the PleurX (©) Catheter. Can J Gastroenterol Hepatol. 2016;2016:4680543. doi: 10.1155/2016/4680543. Epub 2016 Jun 5.
•   Reisfield GM, Wilson GR
  Management of intractable, cirrhotic ascites with an indwelling drainage catheter. J Palliat Med. 2003 Oct;6(5):787-91.
•   Riggio O, Angeloni S, Salvatori FM, De Santis A, Cerini F, Farcomeni A, Attili AF, Merli M
  Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol. 2008 Nov;103(11):2738-46. doi: 10.1111/j.1572-0241.2008.02102.x. Epub 2008 Sep 4.
•   Runyon BA; AASLD
  Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012. Hepatology. 2013 Apr;57(4):1651-3. doi: 10.1002/hep.26359.
•   Saiz-Mendiguren R, Gómez-Ayechu M, Noguera JJ, García-Lallana A, Marginet C, Cano D, Benito A
  [Permanent tunneled drainage for malignant ascites: initial experience with the PleurX® catheter]. Radiologia. 2010 Nov-Dec;52(6):541-5. doi: 10.1016/j.rx.2010.06.005. Epub 2010 Sep 21. Spanish.
•   Savin MA, Kirsch MJ, Romano WJ, Wang SK, Arpasi PJ, Mazon CD
  Peritoneal ports for treatment of intractable ascites. J Vasc Interv Radiol. 2005 Mar;16(3):363-8.
•   Solà E, Watson H, Graupera I, Turón F, Barreto R, Rodríguez E, Pavesi M, Arroyo V, Guevara M, Ginès P
  Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema. J Hepatol. 2012 Dec;57(6):1199-206. doi: 10.1016/j.jhep.2012.07.020. Epub 2012 Jul 20.
•   Tapping CR, Ling L, Razack A
  PleurX drain use in the management of malignant ascites: safety, complications, long-term patency and factors predictive of success. Br J Radiol. 2012 May;85(1013):623-8. doi: 10.1259/bjr/24538524. Epub 2011 Mar 22.
•   Van Waes L, Demeulenaere L
  [Treatment of intractable ascites using continued puncture re-infusion. The Rhodiascit system]. Tijdschr Gastroenterol. 1973;16(6):396-409. Dutch.
•   Watanabe SM, Nekolaichuk C, Beaumont C, Johnson L, Myers J, Strasser F
  A multicenter study comparing two numerical versions of the Edmonton Symptom Assessment System in palliative care patients. J Pain Symptom Manage. 2011 Feb;41(2):456-68. doi: 10.1016/j.jpainsymman.2010.04.020. Epub 2010 Sep 15.
•   White J, Carolan-Rees G
  PleurX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites: a NICE Medical Technology Guidance. Appl Health Econ Health Policy. 2012 Sep 1;10(5):299-308. doi: 10.2165/11634720-000000000-00000. Review.
•   Wilson MM, Thomas DR, Rubenstein LZ, Chibnall JT, Anderson S, Baxi A, Diebold MR, Morley JE
  Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr. 2005 Nov;82(5):1074-81.
•   Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D
  Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut. 1999 Aug;45(2):295-300.

Prospective Evaluation of PleurX Drain for Treatment of Cirrhotic Refractory Ascites

Details for clinical trial NCT04569565